Sonelokimab
Product Specifications
CAS Number
1414386-05-2
Target
Interleukin|||MMP
Related Pathways
Proteases/Proteasome|||Immunology/Inflammation
Bioactivity
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL) -17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6470481-01 0.2 mL
CKBB, NT (Creatine Kinase B-type, Creatine Kinase B Chain, B-CK, CKB) (Biotin)
Ask
View Details 
MBS6470481-02 5x 0.2 mL
CKBB, NT (Creatine Kinase B-type, Creatine Kinase B Chain, B-CK, CKB) (Biotin)
Ask
View Details MBS6337643-01 0.2 mL
PRPF31, CT (PRPF31, PRP31, U4/U6 small nuclear ribonucleoprotein Prp31, Pre-mRNA-processing factor 31, Serologically defined breast cancer antigen NY-BR-99, U4/U6 snRNP 61kD protein) (PE)
Ask
View Details MBS6337643-02 5x 0.2 mL
PRPF31, CT (PRPF31, PRP31, U4/U6 small nuclear ribonucleoprotein Prp31, Pre-mRNA-processing factor 31, Serologically defined breast cancer antigen NY-BR-99, U4/U6 snRNP 61kD protein) (PE)
Ask
View Details